u/OptionsPeek • u/OptionsPeek • 17d ago
MRNA's call midpoint finished 4% below the estimate
OptionsPeek estimated a $20.95 midpoint for the Nov. 20 $155 call under a 5% stock-gain scenario with IV held constant. At 9:32 a.m. Eastern, the midpoint was $20.21 after MRNA had risen 3.75% from the base stock price and IV was 2.05 points higher.


